Presight Capital is a venture capital fund that invests across sectors in the most ambitious founders worldwide, from seed to growth stages.
Our mission isto be steadfast andcommitted to outlierentrepreneurs.
We are a full lifecycle investor and write tickets in the range of 500K to $20M and from seed to growth stages.
Our JourneySince 2019
Assets Under Management
Sectors Invested In
Portfolio Public Listings
AbCellera focuses on the discovery and development process of antibody drugs, the largest and fastest growing class of successful biologic therapeutics.
Angiex is working on using antibody drug conjugates to cure cancer.
Atai is a Nasdaq listed clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. We also invested early in Nasdaq listed Compass Pathways, a subsidiary of ATAI, which is developing psilocybin therapy to help people with treatment-resistant depression.
Bamba is building the universal B2B fintech platform for businesses in Africa.
Bound is building a self-service digital platform that provides forex risk management products to CFOs around the globe.
General Fusion is a clean energy company developing the first commercially-viable fusion power plant.
LILO is creating the next PropTech unicorn in Europe, enabling broader access to real estate investing for a rising cohort of digital-native and high earning consumers.
Perfect Day is leveraging biological engineering and deep learning to mass produce alternative-milk products.
Razor is building the next-gen consumer online conglomerate by aggregating small ecommerce shops first.
Velocity is a revenue-based financing platform for online eCommerce businesses.
E-commerce aggregator Una Brands lands $30M just five months after its Series B
Northstar Group, a regional private equity firm, is the sole investor in Una Brands’ latest round, which involves a mix of equity and debt. The company has now raised more than $100 million in total funding since its inception in 2021.
NewAmsterdam Announces Positive Results from Phase 2 Trial of High Cholesterol Treatment
NewAmsterdam Pharma Company announced topline results from a Phase 2 clinical trial evaluating obicetrapib, the company’s oral, low-dose and once-daily cholesteryl ester transfer protein (“CETP”) inhibitor, in combination with ezetimibe as an adjunct to high-intensity statin therapy.
Alto Neuroscience Announces Positive Phase II Results Supporting Precision Psychiatry Platform
On Day 2 of the annual J.P. Morgan Healthcare Conference, Alto’s founder and CEO Amit Etkin, MD, PhD, details the company’s Precision Psychiatry Platform and the safety and efficacy of ALTO-100 in patients with major depressive disorder (MDD).
Spend Management Platform Alaan Raises $4.5M In Latest Funding Round
UAE-based spend management platform Alaan said Monday that it raised $4.5 million in a Pre-Series A funding round led by Presight Capital and Y Combinator with the participation of other angel investors, bringing its total funding to $7 million.
L Catterton Leads New Investment Round in Razor Group
$70 Million Financing Round led by L Catterton to Support Razor’s Leadership as a Global E-Commerce Operator. Razor Group Acquires VALOREO to Advance Global Growth Strategy.
Alloy Therapeutics Raises $42 Million Series D Financing
Following a successful expansion from antibodies into T-cell receptors and genetic medicines, Alloy will broaden its pre-competitive discovery technology and discovery services to enable innovative new therapeutic formats.
French business bank unicorn Qonto buys German competitor Penta
Qonto, the French business banking unicorn, today announced plans to acquire German fintech Penta. The deal is expected to close in the next few weeks, and will help Qonto push hard into Germany — where it hopes to become the market leader.
Time100 Most Influential Companies 2022: Perfect Day
While most animal-milk alternatives have their own unique tastes and textures, Perfect Day has devised a way of “teaching” microflora to produce milk whey protein, resulting in dairy-identical products with no cows involved.
Set to Reach a Billionaire Valuation Soon, Valoreo Raises $80M
Mexico-based startup Valoreo is one surfing the wave of capital inflows for brand aggregators. After raising a $30 million Series A round in July 2021, the company is now securing its Series B, an $80 million round led by the private equity firm L Catterton.
Flush with cash, bamboo-based toilet paper company Cloud Paper makes it rain
Cloud Paper is a sustainable, bamboo-based alternative to toilet paper made from tree-free materials. The company raised a $5 million round from Bezos Expeditions (the personal investment company of Jeff Bezos), Marc Benioff’s TIME Ventures, Presight Capital, Soundwaves and Jeff Wilke.
Velocity bags $20 Mn in Series A round
Fintech startup Velocity has raised $20 million in a Series A round led by Peter Thiel’s Valar Ventures and other investors including Presight Capital, iSeed, Maninder Gulati, Zac Price and Philippe De Mota.
Berlin’s Razor Group raises $125M at a $1B+ valuation
In the latest development, Berlin’s Razor Group has now raised $125 million of equity funding in a Series B round that CEO and co-founder Tushar Ahluwalia said pushes the company past a $1 billion valuation.
UpScalio raises $42.5 million in funding
A consortium of lenders, including freshly minted unicorn OfBusiness, Innoven Capital, and Alteria Capital, have also committed capital to the platform.
Singapore’s Una Brands raises $40m in one of the region’s largest seed rounds
Singapore-based ecommerce aggregator Una Brands said it has raised US$40 million in its seed round of equity and debt financing, marking one of the biggest seed funding rounds in the region.
International VC firm Presight Capital raises $350M second fund
Presight Capital has closed its $350 million second fund only a year and a half after it announced an $80 million first fund.